Clinical Study

Ucci-Bn-16-01- A Phase 0/1 Exploratory Pharmacokinetic And Pharmacodynamics Study Of Letrozole In Combination With Standard Therapy In Recurrent Gliomas.

Posted Date: May 15, 2019

  • Investigator: Trisha Wise-Draper
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The goal of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in high grade gliomas.

Criteria:

To Be Eligible: Age 18 Or Older, Must Have Recurrent High Grade Glioma, Nonpregnant/Breastfeeding, No Other Uncontrolled Illness

Keywords:

Brain Cancer, Glioma, Phase I, Phase 0

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.